Article Text
Abstract
Objectives To assess whether persons with amyotrophic lateral sclerosis (ALS) are at risk of a therapeutic misconception (TM) in which they misconceive research as treatment or overestimate the likelihood of its benefit.
Methods 72 patients with ALS recruited via academic and patient organisations were surveyed using a hypothetical first-in-human intervention study scenario. We elicited their understanding of the purpose of the study (‘purpose-of-research question’) and then asked how they interpreted the question. We then asked for an estimate of the likelihood that their ALS would improve by participating and asked them to explain the meaning of their estimates.
Results Although 10 of 72 (14%) subjects incorrectly said that the intervention study was ‘mostly intending to help [me]’ in response to the purpose-of-research question, 7 of those 10 thought that the question was asking them about their own motivations for participating. Overall, only one of 72 respondents (1.4%) both understood the purpose-of-research question as intended and gave the incorrect response. Subjects’ mean estimate of likelihood of benefit was 31% (SD 26). This was due to 29 of 72 of respondents providing high estimates (50%–54% likelihood), which they said were expressions of hope and need for a positive attitude; among those who said their estimates meant ‘those are the facts’ or ‘there is a lot of uncertainty’, the estimates were much lower (12.6% and 18.5%, respectively).
Conclusions In this group of patients with ALS considering a hypothetical first-in-human intervention study, apparent TM responses have alternative explanations and the risk of true TM appears low.
- Informed Consent
- Research Ethics
- Clinical trials
- Decision-making
- Research on Special Populations
Statistics from Altmetric.com
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Understanding the ‘therapeutic misconception’ from the research participant’s perspective
- How not to test the prevalence of therapeutic misconception
- Pathophysiological insights into ALS with C9ORF72 expansions
- Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis
- Absence of consensus in diagnostic criteria for familial neurodegenerative diseases
- Amyotrophic lateral sclerosis and motor neuron syndromes in Asia
- Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19
- Parkinson's disease beyond 20 years
- Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?
- The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey